A Phase II Trial of Dovitinib in BCG-Unresponsive...

Clinical Cancer Research 2016 / 12

A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157

Hahn, Noah M., Bivalacqua, Trinity J., Ross, Ashley E., Netto, George J., Baras, Alex, Park, Jong Chul, Chapman, Carolyn, Masterson, Timothy A., Koch, Michael O., Bihrle, Richard, Foster, Richard S.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2267
Date:
December, 2016
File:
PDF, 536 KB
english, 2016
Conversion to is in progress
Conversion to is failed